首页> 外文期刊>Science Immunology >Absence of MHC class II on cDC1 dendritic cells triggersfatal autoimmunity to a cross-presented self-antigen
【24h】

Absence of MHC class II on cDC1 dendritic cells triggersfatal autoimmunity to a cross-presented self-antigen

机译:在CDC1树突状细胞上缺乏MHC II级II触发自身免疫性到交叉表演的自我抗原

获取原文
获取原文并翻译 | 示例
           

摘要

Conventional dendritic cells expressing the XCR1 chemokine receptor (cDC1s) excel at cross-presentation. Here,we developed and used a mouse model in which a Cre recombinase is expressed under the control of the Xcr1gene while preserving XCR1 expression. We used it to generate mice with conditional deletion of MHC class II(MHCII) molecules on cDC1s. By preventing cDC1s to receive suppressive regulatory T cell inputs via MHCII-restrictedinteractions, the objective of the present study was to gauge whether MHCII-deficient cDC1s lose their capacity oftolerizing autoreactive CD8+T cells. Whereas MHCII+cDC1 readily cross-tolerized strongly autoreactive CD8+T cellsspecific for a keratinocyte-derived self-antigen, MHCII-deficient cDC1s converted them into potent effectors capableof triggering a fast-onset lethal autoimmunity associated with severe skin histopathological manifestations. Preventingegress of such pathogenic self-reactive CD8+T cell effectors from the cutaneous draining lymph nodesabrogated the autoimmune condition. Therefore, our results revealed that the cross-tolerizing capacity of cDC1sis not a property fully acquired at the time they undergo homeostatic maturation but needs to be enforced viaMHCII-restricted, suppressive interactions with regulatory T cells.
机译:传统的树突状细胞表达XCR1趋化因子受体(CDC1)在交叉呈现时Excel。在这里,我们开发并使用了小鼠模型,其中在保留XCR1表达的同时,在XCR1Gene的控制下表达CRE重组酶。我们用它来产生与CDC1S上MHC II类(MHCII)分子的条件缺失的小鼠。通过防止CDC1通过MHCII限制性Interlactions接收抑制性的调节T细胞输入,本研究的目的是衡量MHCII缺陷型CDC1是否失去其能力,使其能力降低自动反应性CD8+T细胞。尽管MHCII+CDC1很容易交叉耐耐受性的CD8+T细胞具有针对角质形成衍生的自我抗原的特异性,而MHCII缺陷的CDC1将它们转化为能够触发快速造成的自身自身免疫性与严重的皮肤病学相关的有效效应器,使其具有强有力的效应器。防止皮肤淋巴淋巴结淋巴结淋巴结的这种致病性自我反应性CD8+T细胞效应子的牙和甲基水肿为自身免疫性疾病提供了。因此,我们的结果表明,Cdc1SIS的交叉竞争能力不是在经历稳态成熟时完全获取的特性,而需要强制执行ViamhcII限制性限制,抑制与调节性T细胞的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号